OKYO Pharma Limited Adjustments For Amortisation Expense
OKYO Pharma Limited (OKYO) reported Adjustments For Amortisation Expense of $11.60 thousand for the 12-month period ending 2021-03-31, per its 20-F filed 2023-08-15.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:AdjustmentsForAmortisationExpense · last filed 2023-08-15
| Period end | Adjustments For Amortisation Expense 12 month |
|---|---|
| 2021-03-31 | $11.60K 20-F · filed 2023-08-15 |
| 2020-03-31 | $5.55K 20-F · filed 2022-08-15 |